Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

26.60
+1.516.02%
Post-market: 26.600.00000.00%17:56 EDT
Volume:1.16M
Turnover:30.15M
Market Cap:3.00B
PE:-17.21
High:26.86
Open:24.82
Low:24.81
Close:25.09
52wk High:27.29
52wk Low:14.06
Shares:112.63M
Float Shares:64.72M
Volume Ratio:0.99
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5455
EPS(LYR):-2.5604
ROE:-28.43%
ROA:-17.12%
PB:3.85
PE(LYR):-10.39

Loading ...

Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Oct 28, 2024

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Oct 19, 2024

Correspondence

Form CORRESP - Correspondence
Oct 18, 2024

Major Issues Report

Form 8-K - Current report
Oct 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 23, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Correspondence

Form CORRESP - Correspondence
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 29, 2024

Major Issues Report

Form 8-K - Current report
Jul 18, 2024

Major Issues Report

Form 8-K - Current report
Jul 09, 2024

Correspondence

Form CORRESP - Correspondence
Jul 04, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 11, 2024

Major Issues Report

Form 8-K - Current report